Hsbc Holdings PLC Has $55.68 Million Stock Position in Healthpeak Properties, Inc. $DOC

Hsbc Holdings PLC lifted its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 3.7% during the first quarter, Holdings Channel.com reports. The firm owned 3,384,027 shares of the real estate investment trust’s stock after acquiring an additional 121,425 shares during the quarter. Hsbc Holdings PLC’s holdings in Healthpeak Properties were worth $55,676,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Summit Securities Group LLC raised its position in Healthpeak Properties by 354.9% during the 1st quarter. Summit Securities Group LLC now owns 4,690 shares of the real estate investment trust’s stock worth $77,000 after purchasing an additional 3,659 shares during the last quarter. Beacon Financial Group grew its position in shares of Healthpeak Properties by 16.0% in the 1st quarter. Beacon Financial Group now owns 14,650 shares of the real estate investment trust’s stock valued at $241,000 after buying an additional 2,016 shares during the last quarter. Kestra Advisory Services LLC increased its stake in shares of Healthpeak Properties by 96.3% in the first quarter. Kestra Advisory Services LLC now owns 110,985 shares of the real estate investment trust’s stock valued at $1,823,000 after buying an additional 54,436 shares during the period. Sumitomo Mitsui Trust Group Inc. lifted its stake in shares of Healthpeak Properties by 4.2% in the first quarter. Sumitomo Mitsui Trust Group Inc. now owns 2,406,046 shares of the real estate investment trust’s stock worth $39,531,000 after acquiring an additional 97,710 shares during the period. Finally, Resona Asset Management Co. Ltd. boosted its holdings in Healthpeak Properties by 2.9% in the first quarter. Resona Asset Management Co. Ltd. now owns 416,938 shares of the real estate investment trust’s stock valued at $6,889,000 after acquiring an additional 11,946 shares during the last quarter. 93.57% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

DOC has been the subject of several recent analyst reports. BMO Capital Markets increased their price objective on shares of Healthpeak Properties from $20.00 to $24.00 and gave the stock an “outperform” rating in a research report on Monday, June 15th. Scotiabank boosted their price objective on Healthpeak Properties from $19.00 to $21.00 and gave the company a “sector perform” rating in a research note on Wednesday, May 27th. UBS Group upped their target price on Healthpeak Properties from $19.00 to $21.50 and gave the company a “neutral” rating in a research report on Wednesday, July 8th. Evercore cut Healthpeak Properties from an “outperform” rating to an “in-line” rating and set a $21.00 target price for the company. in a research note on Monday, May 11th. Finally, Robert W. Baird lifted their target price on Healthpeak Properties from $19.00 to $21.00 and gave the stock an “outperform” rating in a report on Wednesday, May 13th. Four analysts have rated the stock with a Buy rating and fifteen have given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $20.62.

Healthpeak Properties Stock Down 1.0%

DOC stock opened at $22.27 on Tuesday. The stock’s 50 day simple moving average is $20.52 and its 200 day simple moving average is $18.30. The company has a market cap of $15.36 billion, a P/E ratio of 69.61, a price-to-earnings-growth ratio of 3.50 and a beta of 1.02. The company has a debt-to-equity ratio of 1.15, a quick ratio of 2.96 and a current ratio of 2.96. Healthpeak Properties, Inc. has a fifty-two week low of $15.70 and a fifty-two week high of $22.72.

Healthpeak Properties (NYSE:DOC) last announced its quarterly earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 EPS for the quarter, beating analysts’ consensus estimates of $0.43 by $0.02. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. The business had revenue of $752.95 million during the quarter, compared to analyst estimates of $694.59 million. During the same quarter in the previous year, the business posted $0.46 EPS. Healthpeak Properties’s quarterly revenue was up 7.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. On average, research analysts expect that Healthpeak Properties, Inc. will post 1.75 earnings per share for the current fiscal year.

Healthpeak Properties Announces Dividend

The firm also recently declared a monthly dividend, which will be paid on Friday, September 25th. Investors of record on Monday, September 14th will be given a $0.1017 dividend. The ex-dividend date of this dividend is Monday, September 14th. This represents a c) annualized dividend and a yield of 5.5%. Healthpeak Properties’s dividend payout ratio (DPR) is presently 381.25%.

Insiders Place Their Bets

In other Healthpeak Properties news, insider Scott R. Bohn sold 10,989 shares of Healthpeak Properties stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total transaction of $213,736.05. Following the completion of the transaction, the insider owned 7,636 shares in the company, valued at approximately $148,520.20. The trade was a 59.00% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.23% of the company’s stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.